Pompe Disease Market Set for Expansion During the Forecast Period (2026-2036) as Growth is Fueled by Next-Generation ERTs, Newborn Screening, and Pipeline Innovation | DelveInsight

Summary

Market analysis report forecasts significant growth in the Pompe disease market from 2026-2036, driven by next-generation enzyme replacement therapies and pipeline innovations from multiple companies including Shionogi, Maze Therapeutics, Astellas Pharma, Bayer, and Denali Therapeutics.